Publication | Open Access

Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter]

Hematological MalignancyFollow-up ConfirmsMedicineMixed-phenotype Acute LeukemiaPharmacologyPharmacotherapyOncologyRadiation OncologyAcute Promyelocytic LeukemiaCancer ResearchAll-trans Retinoic Acid